TSHA – taysha gene therapies, inc. (US:NASDAQ)
Stock Stats
News
Taysha Gene Therapies (NASDAQ:TSHA) was given a new $11.00 price target on by analysts at UBS Group AG.
Taysha Gene Therapies (NASDAQ:TSHA) was upgraded by analysts at The Goldman Sachs Group, Inc. to a "buy" rating.
Taysha Gene Therapies (NASDAQ:TSHA) was given a new $11.00 price target on by analysts at The Goldman Sachs Group, Inc..
Taysha Gene Therapies (NASDAQ:TSHA) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Taysha Gene Therapies (NASDAQ:TSHA) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Form 4 Taysha Gene Therapies, For: Nov 28 Filed by: Nagendran Sukumar
Form 144 Taysha Gene Therapies, Filed by: Nagendran Sukumar
Form SCHEDULE 13G/A Taysha Gene Therapies, Filed by: Octagon Capital Advisors LP
Form SCHEDULE 13G/A Taysha Gene Therapies, Filed by: RA CAPITAL MANAGEMENT, L.P.
Form S-3ASR Taysha Gene Therapies,
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.